Optigenex

Melissa, United States Founded: 2002 • Age: 24 yrs Listed
Optigenex is focused on healthy aging technology development.

About Optigenex

Optigenex is a publicly listed company based in Melissa (United States) founded in 2002 by Edward P. Optigenex is focused on healthy aging technology development. It operates on a Licensing Model model. Optigenex offers products and services including ac-11®. Its focus areas include Biotechnology and Natural Supplements. Its legal entity is Optigenex Inc. Its competitors include Biote, Timeline and Ponce De Leon Health.

Company details

Optigenex is engaged in developing patented, all-natural technologies for healthy aging, targeting the dietary supplement and skincare industries. Solutions are based on ac-11, a hot water extract of Uncaria tomentosa from the Amazon rainforest, aimed at supporting DNA repair. Research and sustainability are emphasized, with operations compliant with USDA, ISO 9002, FDA regulations, and GMP standards. Licensing opportunities are offered to manufacturers, distributors, and retailers worldwide.

  • Headquarters Melissa, United States
  • Founders Edward P
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website optigenex.com
  • Social LinkedIn
  • Legal Name Optigenex Inc
Key Metrics
  • Latest Funding Round
    $630K (USD), Post-IPO

    Nov 2017

Products & Services of Optigenex

Optigenex offers a comprehensive portfolio of products and services, including ac-11®.

ac-11®
Dietary Supplement & Skincare

Extract of Uncaria tomentosa supporting DNA repair naturally.

Funding Insights of Optigenex

  • Total Rounds 1
  • Last Round Post-IPO — $630,000
  • First Round $630,000

    (Nov 2017)

All 1 funding rounds of Optigenex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2017$630,000Post-IPO––
–

People of Optigenex

1 people are tracked at Optigenex (1 in leadership).

NameRoleGroup
Edward P
FounderLeadership
Premium access

Complete people profiles for Optigenex

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Optigenex

Optigenex is a publicly listed company on the OTC with ticker symbol OPGX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 Apr 2005
  • Listed onOTCMKTS: OPGX
  • Listed entityOPTIGENEX INC
  • Exchange sectorHealth technology
  • ISINUS6838863032
  • Share price$0.00 · 2026-05-11
  • Volume (last session)628
  • Analyst consensusNo rating

Timeline of Optigenex

3 dated milestones of Optigenex across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Optigenex is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $630K.

Competitors of Optigenex

Optigenex has 3 listed competitors in our database. They include Biote, Timeline and Ponce De Leon Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biote.com2011Irving, United States
Hormone replacement and pellet therapy services are offered.
timeline.com2007San Francisco, United States
Clinically-tested Urolithin A supplements and skincare are developed.
pdlhealth.com2014Fernandina Beach, United States
Anti-aging nutraceutical supplements are developed and tested.
Premium access

Detailed competitors of Optigenex

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Optigenex

The website of Optigenex (optigenex.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K

    ▼ 1.4% vs previous month

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Optigenex (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Optigenex

Optigenex was founded in 2002 and raised its 1st funding round 15 years after it was founded.

Optigenex is headquartered in Melissa, United States. It is registered at Melissa, Texas, United States.

Optigenex is engaged in developing patented, all-natural technologies for healthy aging, targeting the dietary supplement and skincare industries. Solutions are based on ac-11, a hot water extract of Uncaria tomentosa from the Amazon rainforest, aimed at supporting DNA repair. Research and sustainability are emphasized, with operations compliant with USDA, ISO 9002, FDA regulations, and GMP standards. Licensing opportunities are offered to manufacturers, distributors, and retailers worldwide.

Optigenex's top competitors include Biote, Timeline and Ponce De Leon Health.

Optigenex offers ac-11®.

Yes, Optigenex is publicly traded on OTC under the ticker symbol OPGX.

Optigenex operates through Optigenex Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available